Umberto Capasso Palmiero

Umberto Capasso Palmiero

Company: Novo Nordisk

Job title: Senior Scientist

Seminars:

Roundtable: Discussing the Impact of PEG on Safety & Immunogenicity Studies to Indicate Potential Solutions 11:30 am

Reviewing how PEG impacts preclinical and clinical safety studies for vaccines, gene and cell therapies Discussing solutions and approaches to minimize this impact and generate robust safety data Understanding and minimizing unwanted infusion associated reactions stimulated by PEG lipids How will PEG lipids impact multi-dosing strategies?Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.